Andrew Wang, MD


Professor of Medicine
Director, Cardiovascular Disease Fellowship Program
Department / Division:
Medicine / Medicine - Cardiology
Address:
DUMC 3428
Durham, NC 27710
Appointment Telephone:
919-681-5816
Office Telephone:
919-681-6197
Fax:
919-681-7917
Training:
  • MD, Duke University School of Medicine, 1990
Residency:
  • Internal Medicine, Johns Hopkins Hospital (Maryland), 1990-1993, 1994-1995
Fellowship:
  • Cardiology, Duke University Medical Center, 1993-1994, 1995-1997
Clinical Interests:
Structural heart disease, including valvular heart disease, mitral valve disease, aortic valve disease; percutaneous valve intervention; valvuloplasty; cardiac catheterization; hypertrophic cardiomyopathy; adult congenital heart disease; endocarditis; general cardiology
Research Interests:
Structural heart diseases, including valvular heart disease, hemodynamics, infective endocarditis, and hypertrophic cardiomyopathy
Representative Publications:
  • Athan, E; Chu, VH; Tattevin, P; Selton-Suty, C; Jones, P; Naber, C; Miró, JM; Ninot, S; Fernández-Hidalgo, N; Durante-Mangoni, E; Spelman, D; Hoen, B; Lejko-Zupanc, T; Cecchi, E; Thuny, F; Hannan, MM; Pappas, P; Henry, M; Jr, VGF; Crowley, AL; Wang, A. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA: Journal of the American Medical Association. 2012;307:1727-1735.  Abstract
  • Herrmann, HC; Gertz, ZM; Silvestry, FE; Wiegers, SE; Woo, YJ; Hermiller, J; Segar, D; Heimansohn, D; Gray, W; Homma, S; Argenziano, M; Wang, A; Jollis, J; Lampert, MB; Alexander, J; Mauri, L; Foster, E; Glower, D; Feldman, T. Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular valve edge-to-edge repair study) randomized trial. Journal of the American College of Cardiology. 2012;59:1312-1319.  Abstract
  • Kiefer, T; Park, L; Tribouilloy, C; Cortes, C; Casillo, R; Chu, V; Delahaye, F; Durante-Mangoni, E; Edathodu, J; Falces, C; Logar, M; Miró, JM; Naber, C; Tripodi, MF; Murdoch, DR; Moreillon, P; Utili, R; Wang, A. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA: Journal of the American Medical Association. 2011;306:2239-2247.  Abstract
  • Nagueh, SF; Groves, BM; Schwartz, L; Smith, KM; Wang, A; Bach, RG; Nielsen, C; Leya, F; Buergler, JM; Rowe, SK; Woo, A; Maldonado, YM; Spencer, WH. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. Journal of the American College of Cardiology. 2011;58:2322-2328.  Abstract
  • Coeytaux, RR; Williams, JW; Gray, RN; Wang, A. Percutaneous heart valve replacement for aortic stenosis: state of the evidence. Annals of Internal Medicine. 2010;153:314-324.  Abstract
  • Lalani, T; Cabell, CH; Benjamin, DK; Lasca, O; Naber, C; Fowler, VG; Corey, GR; Chu, VH; Fenely, M; Pachirat, O; Tan, RS; Watkin, R; Ionac, A; Moreno, A; Mestres, CA; Casabé, J; Chipigina, N; Eisen, DP; Spelman, D; Delahaye, F; Peterson, G; Olaison, L; Wang, A; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005-1013.  Abstract
  • Leonardi, RA; Kransdorf, EP; Simel, DL; Wang, A. Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment. Circulation: Cardiovascular Interventions. 2010;3:97-104.  Abstract
  • Murdoch, DR; Corey, GR; Hoen, B; Miró, JM; Fowler, VG; Bayer, AS; Karchmer, AW; Olaison, L; Pappas, PA; Moreillon, P; Chambers, ST; Chu, VH; Falcó, V; Holland, DJ; Jones, P; Klein, JL; Raymond, NJ; Read, KM; Tripodi, MF; Utili, R; Wang, A; Woods, CW; Cabell, CH; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of Internal Medicine. 2009;169:463-473.  Abstract
  • Thomas, MP; Wang, A. Clinical problem-solving. Taken out of context. New England Journal of Medicine. 2008;359:2478-2482.  Abstract
  • Aksoy, O; Sexton, DJ; Wang, A; Pappas, PA; Kourany, W; Chu, V; Fowler, VG; Woods, CW; Engemann, JJ; Corey, GR; Harding, T; Cabell, CH. Early surgery in patients with infective endocarditis: a propensity score analysis. Clinical Infectious Diseases. 2007;44:364-372.  Abstract
  • Wang, A; Athan, E; Pappas, PA; Fowler, VG; Olaison, L; Paré, C; Almirante, B; Muñoz, P; Rizzi, M; Naber, C; Logar, M; Tattevin, P; Iarussi, DL; Selton-Suty, C; Jones, SB; Casabé, J; Morris, A; Corey, GR; Cabell, CH; International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA: Journal of the American Medical Association. 2007;297:1354-1361.  Abstract
  • Cabell, CH; Abrutyn, E; Fowler, VG; Hoen, B; Miro, JM; Corey, GR; Olaison, L; Pappas, P; Anstrom, KJ; Stafford, JA; Eykyn, S; Habib, G; Mestres, CA; Wang, A; International Collaboration on Endocarditis Merged Database (ICE-MD) Study Group Investigators. Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. American Heart Journal. 2005;150:1092-1098.  Abstract
  • Wang, A; Pappas, P; Anstrom, KJ; Abrutyn, E; Fowler, VG; Hoen, B; Miro, JM; Corey, GR; Olaison, L; Stafford, JA; Mestres, CA; Cabell, CH; International Collaboration on Endocarditis Investigators. The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. American Heart Journal. 2005;150:1086-1091.  Abstract
  • Chu, VH; Cabell, CH; Benjamin, DK; Kuniholm, EF; Fowler, VG; Engemann, J; Sexton, DJ; Corey, GR; Wang, A. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109:1745-1749.  Abstract
  • Stone, GW; McCullough, PA; Tumlin, JA; Lepor, NE; Madyoon, H; Murray, P; Wang, A; Chu, AA; Schaer, GL; Stevens, M; Wilensky, RL; O'Neill, WW; CONTRAST Investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA: Journal of the American Medical Association. 2003;290:2284-2291.  Abstract
  • Wang, A; Jaggers, J; Ungerleider, RM; Lim, CS; Ryan, T. Exercise echocardiographic comparison of pulmonary autograft and aortic homograft replacements for aortic valve disease in adults. The Journal of Heart Valve Disease. 2003;12:202-208.  Abstract
  • Tumlin, JA; Wang, A; Murray, PT; Mathur, VS. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. American Heart Journal. 2002;143:894-903.  Abstract
end fo content area